Headache Pathophysiology, Vascular Mechanisms, and Phytotherapeutic Strategies

Comprehensive guide relating to headache herbalism covering vascular mechanisms, tension etiology, migraine pathophysiology, and referred pain patterns. Western neurology, headache classification, phytochemical analgesic/anti-inflammatory mechanisms.

---

Table of Contents

1. Headache Pathophysiology
2. Tension Headache Mechanisms
3. Peppermint: TRPM8 Activation and Pain Modulation
4. Lavender: GABAergic Anxiolysis
5. Feverfew: Migraine Prevention Pharmacology
6. Ginger in Headache and Migraine
7. Clinical Application and Formulation
8. References

---

Headache Pathophysiology

Classification and Epidemiology

International Classification of Headache Disorders (ICHD-3):

Primary headaches (no underlying pathology):

• Tension-type headache (TTH): ~40% of population
• Migraine: ~15% of population (3:1 female:male)
• Cluster headache: Rare (~0.1%)

Secondary headaches (underlying cause):

• Infection, trauma, vascular disorders, medication overuse
• Red flags require medical evaluation

Neuroanatomy of Head Pain

Trigeminal system:

Trigeminal nerve (CN V):

• Largest cranial nerve
• Three divisions:
• V1 (Ophthalmic): Forehead, scalp, eye – V2 (Maxillary): Midface, upper teeth, sinuses – V3 (Mandibular): Lower face, jaw, lower teeth

Trigeminal ganglion:

• Contains cell bodies of primary sensory neurons
• Located in Meckel’s cave (middle cranial fossa)

Central projections:

• Primary afferents → trigeminal nucleus caudalis (TNC) in brainstem
• TNC = “spinal trigeminal nucleus”
• Extends into upper cervical spinal cord (C1-C2)
• Trigeminocervical complex: Explains overlap between neck tension and headache

Pain-sensitive structures:

• Intracranial:
• Dura mater (outer meningeal layer) – Large arteries (circle of Willis branches) – Venous sinuses – Brain parenchyma itself NOT pain-sensitive
• Extracranial:
• Scalp, muscles, periosteum – Temporomandibular joint (TMJ) – Cervical muscles/joints

Nociceptive Processing in Headache

Peripheral sensitisation:

• Release of inflammatory mediators from meningeal nociceptors:
• Substance P – CGRP (calcitonin gene-related peptide) – Neurokinin A
• These cause neurogenic inflammation:
• Vasodilation – Mast cell degranulation – Increased vascular permeability – Positive feedback: More inflammation → more nociceptor activation

Central sensitisation:

• TNC hyperexcitability:
• Enhanced synaptic transmission – Increased receptive field size – Reduced pain threshold
• Mechanisms:
• NMDA receptor activation (glutamate) – Substance P/NK1 receptor signaling – Loss of inhibitory control (GABAergic, glycinergic)
• Clinical manifestation:
• Allodynia (normally non-painful stimuli hurt — brushing hair painful) – Cutaneous hypersensitivity – Spread of pain beyond initial area

---

Tension Headache Mechanisms

Muscle Contraction vs Central Mechanisms

Historical “muscle contraction headache” theory:

• Sustained contraction of pericranial muscles (scalp, neck, jaw)
• Ischemia in contracted muscle
• Accumulation of pain mediators (bradykinin, lactate)

Evidence problems:

• EMG studies show inconsistent muscle activity elevation in TTH
• Some TTH patients have normal muscle tension
• Current understanding: More complex

Modern Mechanistic Model

Peripheral factors (episodic TTH):

• Myofascial nociception:
• Tender points in pericranial muscles – Trigger points (especially upper trapezius, temporalis, suboccipitals) – Release of sensitising substances (ATP, bradykinin, substance P)
• Inflammation:
• Low-grade inflammation in muscle and fascia – Elevated TNF-α, IL-1β in tender points – PGE2 from COX-2

Central factors (chronic TTH):

• Central sensitisation in TNC:
• Second-order neurons become hyperexcitable – Wind-up phenomenon (progressive increase in response to repeated stimuli) – Expanded receptive fields
• Descending pain modulation dysfunction:
• Normally: Periaqueductal gray (PAG) and rostral ventromedial medulla (RVM) send inhibitory signals to TNC – In chronic TTH: Reduced inhibition or facilitation – Serotonergic and noradrenergic pathways involved

Psychosocial factors:

• Stress:
• Activates sympathetic nervous system – Increases muscle tone via gamma motor neurons – Modulates pain processing (limbic system)
• Depression/anxiety:
• Comorbid in >50% chronic TTH – Share neurochemical pathways with pain (serotonin, norepinephrine) – Bidirectional relationship (pain → mood changes; mood disorders → pain)

Neurochemistry of TTH

Nitric oxide (NO):

• Role in headache:
• Vasodilator – Modulates nociceptive transmission – NO donors (nitroglycerin) can trigger headache
• In TTH:
• Possibly elevated NO in chronic TTH – Contributes to central sensitisation

Serotonin (5-HT):

• Complex role:
• Low levels associated with chronic pain states – 5-HT modulates descending inhibition
• In TTH:
• Possible serotonergic dysfunction – Tricyclic antidepressants (5-HT/NE reuptake inhibitors) effective for chronic TTH

Substance P:

• Neuropeptide in pain transmission
• Elevated in chronic pain conditions
• In TTH:
• May be elevated in cerebrospinal fluid – Correlates with pain intensity

Peppermint: TRPM8 Activation and Pain Modulation

Menthol Phytochemistry

(-)-Menthol:

• Monoterpene alcohol
• Molecular formula: C10H20O
• Peppermint oil content: 30-50% menthol
• Isomers: (-)-menthol is the predominant and most active form

Peppermint oil (Mentha × piperita):

• Hybrid species: M. aquatica × M. spicata
• Composition:
• Menthol: 30-50% – Menthone: 14-32% – Menthyl acetate: 3-10% – 1,8-Cineole: 3-6% – Limonene: 1-5%

Mechanisms of Action

1. TRPM8 Receptor Activation:

TRPM8 (Transient Receptor Potential Melastatin 8):

• Type: Non-selective cation channel (Ca²⁺, Na⁺)
• Location:
• Primary sensory neurons (Aδ and C fibres) – Trigeminal ganglia (relevant for headache) – DRG (dorsal root ganglia)
• Physiological activators:
• Cold (<26°C) – Voltage
• Pharmacological activator: Menthol

Menthol binding:

• Binds intracellular site on TRPM8
• Lowers activation threshold (opens at ~15°C warmer than usual)
• Channel opens at room/skin temperature
• Ca²⁺ influx → depolarisation
• Perception: Cooling sensation (even though temperature unchanged)

2. Counter-Irritant Effect (Gate Control Theory):

Gate Control Theory (Melzack & Wall, 1965):

• Concept: Non-nociceptive input can inhibit pain signals at spinal cord level
• Mechanism:
• Large-diameter Aβ fibres (light touch, pressure) activate inhibitory interneurons in dorsal horn – Interneurons release GABA, glycine – Inhibit second-order nociceptive neurons – “Close the gate” to pain transmission

Menthol application:

• Activates TRPM8 on Aδ fibres (cool receptors)
• Aδ input: Travels faster than C-fibre pain input
• Activates spinal inhibitory circuits
• Result: Cooling sensation competes with/reduces pain signals

3. Analgesic Effects (Beyond Cooling):

Local anesthetic-like action:

• Menthol can block voltage-gated sodium channels (Nav)
• Reduces neuronal excitability
• Concentration-dependent: High concentrations (topical) more effective

μ-Opioid receptor agonism:

• Menthol has weak μ-opioid agonist activity
• May contribute to analgesic effect
• Not primary mechanism but additive

Calcium channel modulation:

• Menthol affects voltage-gated calcium channels
• Reduces neurotransmitter release (including glutamate)
• Decreases synaptic transmission

4. Smooth Muscle Effects:

Relevant for tension headache:

• Vascular smooth muscle:
• Menthol causes vasodilation via Ca²⁺ channel effects – Improved blood flow – May reduce ischemic muscle pain component
• Skeletal muscle relaxation:
• Indirect via sensory effects – Cooling sensation → perceived relaxation

Clinical Evidence for Peppermint in Headache

Gbel et al. (1996) Classic Study:

• 41 patients with tension headache
• Design: Randomised, placebo-controlled, crossover
• Intervention: 10% peppermint oil in ethanol solution applied to forehead and temples
• Control: Placebo (ethanol only), 1g paracetamol (acetaminophen)
• Results:
• Peppermint oil as effective as 1g paracetamol – Significant reduction in headache intensity (clinical and pain threshold measurements) – Effect within 15-30 minutes – Well tolerated

Mechanism demonstrated:

• EEG changes showed increased α-power (relaxation)
• Reduced muscle tension (EMG)

Application and Pharmacokinetics

Topical application:

Penetration:

• Menthol is lipophilic (log P ~3.4)
• Penetrates stratum corneum readily
• Reaches dermis and subcutaneous tissue

Metabolism:

• Absorbed menthol undergoes hepatic glucuronidation
• Excreted in urine as menthol glucuronide
• Minimal systemic effects from topical use

Optimal formulation for headache:

• 10% menthol in carrier (ethanol, oil)
• Application sites: Temples, forehead, back of neck
• Avoid eyes: Strong irritant to eyes (TRPM8 highly expressed)
• Reapplication: Every 1-2 hours as needed

Aromatherapy effects:

• Inhalation activates olfactory system
• Limbic connections: Affect mood, anxiety
• May contribute to headache relief (stress reduction)

---

Lavender: GABAergic Anxiolysis

Phytochemistry

Lavender essential oil (Lavandula angustifolia):

Major constituents:

• Linalool: 25-38% (monoterpene alcohol)
• Linalyl acetate: 25-45% (ester)
• 1,8-Cineole (Eucalyptol): 0.5-2.5%
• Camphor: 0.5-1.5%
• β-Caryophyllene: 2-5% (sesquiterpene)

Chemotypes:

• High linalool/linalyl acetate = therapeutic grade
• High camphor = less desirable (can be stimulating vs calming)

Mechanisms in Headache Relief

1. GABAergic Modulation:

GABA (γ-Aminobutyric acid):

• Primary inhibitory neurotransmitter in CNS
• GABA-A receptors: Ligand-gated chloride channels
• Activation → Clā influx → hyperpolarisation → inhibition

Linalool mechanism:

• Positive allosteric modulator of GABA-A receptors
• Binds site distinct from GABA binding site
• Enhances GABA’s effect (increases channel open time/frequency)
• Similar to benzodiazepines but much weaker, no dependence

Effects:

• Reduces neuronal excitability throughout CNS
• Anxiolysis (anti-anxiety)
• Mild sedation (at higher doses)
• Muscle relaxation (via spinal GABA-A receptors)

Relevance to tension headache:

• Anxiety and stress → muscle tension → headache
• GABA-A enhancement → reduced anxiety → reduced muscle tension → headache relief
• Breaks the stress-pain cycle

2. Adenosine System Modulation:

Adenosine:

• Neuromodulator (inhibitory)
• Promotes sleep, reduces arousal
• Anti-inflammatory

Lavender effects:

• May enhance adenosine signaling
• Contributes to calming effect

3. Calcium Channel Effects:

Voltage-gated calcium channels:

• Essential for neurotransmitter release
• Neuronal excitability

Linalool:

• Blocks certain calcium channels (L-type, N-type)
• Reduces neurotransmitter release
• Decreases neuronal activity
• Synergises with GABA effects

4. Anti-Inflammatory Effects:

Linalool and linalyl acetate:

• Reduce pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6)
• Inhibit NF-κB activation
• May address inflammatory component of tension headache

Clinical Evidence

Sasannejad et al. (2012) — Lavender for Migraine:

• 47 patients with acute migraine
• Design: Randomised controlled trial
• Intervention: Inhale lavender essential oil for 15 minutes vs placebo (liquid paraffin)
• Results:
• 74% of lavender group had partial or complete headache relief – 47% of placebo group (significant difference) – Effect within 15 minutes – No adverse effects

Mechanism in migraine:

• Likely via anxiolysis and stress reduction (migraine often stress-triggered)
• Possible mild analgesic effects
• Improved parasympathetic tone

Aromatherapy studies (multiple):

• Lavender inhalation reduces anxiety in various settings
• Reduces cortisol levels (stress hormone)
• Improves mood
• All contribute to headache relief (especially stress-related)

Routes of Administration

Inhalation (aromatherapy):

Olfactory pathway:

1. Volatile compounds → olfactory epithelium (nasal cavity)
2. Bind olfactory receptors
3. Signal → olfactory bulb → limbic system (amygdala, hippocampus)
4. Direct emotional/stress response modulation

Also:

• Small amounts absorbed through nasal mucosa → systemic circulation
• Reaches brain via blood

For headache:

• 2-4 drops on tissue, inhale deeply
• OR diffuser in room
• 10-15 minutes

Topical application:

Absorption:

• Lipophilic components penetrate skin
• Enter circulation
• Distribute to CNS

For headache:

• 2-3 drops diluted in carrier oil
• Apply to temples, forehead
• Gentle massage
• Avoid eyes

Combines mechanisms:

• Local effects (cooling from evaporation)
• Aromatherapy (inhalation)
• Systemic absorption

Oral (less common for acute headache):

• Lavender oil capsules available
• Used more for anxiety, sleep
• Silexan®: Proprietary lavender oil preparation, clinically studied for anxiety
• Dose: 80-160mg daily

---

Feverfew: Migraine Prevention Pharmacology

Phytochemistry

Tanacetum parthenium (Feverfew):

Active constituent:

• Parthenolide: Sesquiterpene lactone (0.1-0.9% in dried leaves)
• Structure: Germacranolide with α-methylene-γ-lactone and epoxide groups

Other constituents:

• Sesquiterpene lactones: Various related compounds
• Flavonoids: Apigenin, luteolin
• Volatile oils: Camphor, terpenes

Variation:

• Parthenolide content varies widely by cultivar, growing conditions
• Standardisation essential: Products should specify parthenolide content (minimum 0.2%)

Mechanisms in Migraine Prevention

1. Serotonin (5-HT) Modulation:

Serotonin in migraine pathophysiology:

• Platelet aggregation: Releases 5-HT
• Vasoconstriction: 5-HT causes cranial artery constriction
• Depletion phase: Subsequent vasodilation (rebound)
• Cortical spreading depression: 5-HT involved in aura

Parthenolide effects:

• Inhibits serotonin release from platelets
• Prevents platelet aggregation
• stabilises vascular tone (prevents vasoconstriction-dilation cycle)

Mechanism:

• Parthenolide alkylates sulfhydryl groups in proteins involved in granule secretion
• Reduces stored 5-HT release

2. Prostaglandin Synthesis Inhibition:

Phospholipase A2 (PLA2) inhibition:

• PLA2 releases arachidonic acid from membranes (first step in prostaglandin synthesis)
• Parthenolide inhibits PLA2
• Reduces prostaglandin production (especially PGE2)
• Less pain sensitisation, inflammation

COX pathway:

• Some studies suggest direct COX inhibition
• Less consistent than PLA2 inhibition

3. NF-κB Inhibition:

Mechanism:

• Parthenolide alkylates p65 subunit (similar to helenalin in arnica)
• Prevents NF-κB DNA binding
• Reduces inflammatory gene expression

Relevance to migraine:

• Neurogenic inflammation in meninges involves cytokines
• NF-κB inhibition reduces inflammatory component

4. TRPA1 Modulation:

TRPA1 (Transient Receptor Potential Ankyrin 1):

• Ion channel on sensory neurons
• Activated by irritants, inflammatory mediators
• Expressed in trigeminal neurons

Parthenolide:

• Initially activates TRPA1 (may cause oral irritation when chewing fresh leaves)
• Prolonged exposure desensitises TRPA1
• May reduce trigeminal nociceptor excitability

Clinical Evidence

Murphy et al. (1988) — Landmark Study:

• 72 patients with migraine
• Design: Randomised, double-blind, placebo-controlled, crossover
• Duration: 4 months each phase
• Intervention: Dried feverfew leaves (82mg daily, ~0.66mg parthenolide)
• Results:
• 24% reduction in migraine frequency – Reduced severity and duration of attacks – Less nausea/vomiting – Effect took 4-6 weeks to manifest

Pittler & Ernst (2004) — Cochrane Review:

• Meta-analysis of feverfew for migraine prevention
• Conclusion:
• Evidence suggests efficacy but variable quality of studies – Standardisation issues (parthenolide content) – More research needed but promising

Cochrane updated 2015:

• Insufficient high-quality evidence to confidently recommend
• Issue: Many studies pre-standardisation era
• Modern standardised extracts likely more consistent

Practical Considerations

For prevention only:

• NOT for acute migraine treatment
• Requires continuous daily use
• Onset: 4-6 weeks before benefit seen
• Must continue indefinitely (stopping = return of migraines)

Dosing:

• Fresh leaves: 1-3 leaves daily (traditional — bitter, may cause mouth ulcers)
• Dried standardised extract: 50-150mg daily (minimum 0.2% parthenolide)
• Capsules: 100-300mg daily of standardised extract

Safety:

• Generally well tolerated
• Mouth ulcers: From fresh leaves (allergic contact stomatitis)
• GI upset: Possible
• “Post-feverfew syndrome”: Rebound headaches, anxiety, sleep disturbance if stopped abruptly after long use (taper off slowly)
• Contraindications:
• Pregnancy (uterine stimulant potential) – Anticoagulants (antiplatelet effects) – Allergy to Asteraceae family

---

Clinical Application and Formulation

Headache-Type Specific Approaches

Tension Headache:

First-line herbal:

1. Peppermint oil (topical): 10% in carrier oil or ethanol

• Apply to temples, forehead, back of neck – At onset and every 1-2 hours as needed

1. Lavender (aromatherapy + topical):

• 2-4 drops inhaled from tissue – Diluted and applied to temples – At onset

Adjunctive:

• Ginger tea: If inflammation suspected (chronic TTH)
• Magnesium: Not herbal but synergistic (400mg daily — many deficient)

Preventive (chronic TTH):

• Stress reduction practices
• Regular lavender aromatherapy before bed
• Address underlying triggers (posture, stress)

Migraine:

Prevention (requires medical diagnosis):

1. Feverfew: 100-300mg standardised extract daily

• Start 4-6 weeks before expected benefit – Continue indefinitely – Do not stop abruptly

Acute treatment:

1. Ginger: 2g at onset (anti-nausea, anti-inflammatory)
2. Peppermint oil: Topical (may help in some individuals)
3. Lavender: Inhalation (stress-triggered migraines)

Note: Severe migraines may require pharmaceutical intervention (triptans, etc.) — herbs are adjunctive

Sinus Headache:

Primary strategy: Address sinus inflammation

1. Ginger (internal):

• Strong tea (3-5cm fresh root simmered 15 min) – 2-3 cups daily – Anti-inflammatory, thins mucus

1. Peppermint steam:

• 3-5 drops in bowl of hot water – Inhale (eyes closed) 10 minutes – Opens sinuses, antimicrobial

Synergy: Both open sinuses, reduce inflammation, address cause

Formulation Examples

Tension Headache Relief Blend:

Topical roll-on:

• Base: 10ml carrier oil (jojoba, sweet almond)
• Essential oils:
• Peppermint: 20 drops (~10%) – Lavender: 10 drops (~5%) – Rosemary (optional): 5 drops (~2.5%) (circulation)
• Method:
• Combine in 10ml roll-on bottle – Shake well before each use – Roll on temples, forehead, back of neck at headache onset – Repeat hourly as needed

Why this works:

• Peppermint: TRPM8 cooling, counter-irritant, mild analgesic
• Lavender: GABA-ergic calming, stress reduction
• Rosemary: Improves circulation, mild analgesic
• Synergistic: Multiple mechanisms

Migraine Prevention Tea:

For daily use (if diagnosed with migraines):

• Feverfew leaf: 1-2 teaspoons dried (or 1-2 fresh leaves)
• Ginger root: 1 teaspoon fresh grated or 1/2 tsp dried
• Chamomile flowers: 1 teaspoon (calming, mild anti-inflammatory)

Method:

• Steep all together in 500ml hot water, 10-15 minutes
• Strain
• Drink 1-2 cups daily

Note: Fresh feverfew leaves very bitter — capsules may be preferable

Acute Headache Relief Tea:

At onset:

• Ginger root: 5cm piece, sliced
• Peppermint leaf: 2 teaspoons dried or small handful fresh
• Lavender flowers: 1/2 teaspoon (don’t overdo — can be overpowering)
• Optional honey

Method:

• Simmer ginger 10 minutes
• Remove from heat
• Add peppermint and lavender
• Steep covered 10 minutes
• Strain, add honey
• Sip slowly in quiet, dark space

Why this works:

• Ginger: Anti-inflammatory, anti-nausea
• Peppermint: Internal cooling, mild analgesic, calming GI (if nauseous)
• Lavender: Anxiolytic, relaxing
• Ritual: Preparation and mindful sipping = stress reduction

---

References

Gbel, H., Schmidt, G., & Soyka, D. (1996). Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia, 14(3), 228-234.

Sasannejad, P., Saeedi, M., Shoeibi, A., Gorji, A., Abbasi, M., & Foroughipour, M. (2012). Lavender essential oil in the treatment of migraine headache: A placebo-controlled clinical trial. European Neurology, 67(5), 288-291.

Murphy, J. J., Heptinstall, S., & Mitchell, J. R. (1988). Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet, 2(8604), 189-192.

Pittler, M. H., & Ernst, E. (2004). Feverfew for preventing migraine. Cochrane Database of Systematic Reviews, (1), CD002286.

Peikert, A., Wilimzig, C., & Khne-Volland, R. (1996). Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-centre, placebo-controlled and double-blind randomised study. Cephalalgia, 16(4), 257-263.

Bone, K., & Mills, S. (2013). Principles and practice of phytotherapy: Modern herbal medicine (2nd ed.). Churchill Livingstone.

---

Rongoā Māori Disclaimer: This guide does not represent rongoā Māori preparation methods or traditional Māori medicine-making. Rongoā Māori is a complete healing system with its own protocols, karakia (prayers), and cultural practices that cannot be separated from te ao Māori (the Māori worldview). For rongoā Māori knowledge and treatment, please consult qualified rongoā practitioners through Te Paepae Motuhake or other appropriate Māori health services.

Medical Disclaimer: This guide is for educational purposes only and is not medical advice. Herbal preparations can interact with medications, cause allergic reactions, and may be contraindicated in certain health conditions. Always consult qualified healthcare practitioners before using herbal medicines, especially if you are pregnant, nursing, taking medications, or have medical conditions. You are solely responsible for correct plant identification, safe preparation practices, and appropriate use. The information presented represents current scientific understanding, which continues to evolve.

Note on Pricing: All prices mentioned in this guide are approximate and based on New Zealand suppliers as of January 2026. Prices vary by supplier, season, and market conditions. We recommend checking current prices with your local suppliers.